C9053 is a valid 2023 HCPCS Code that could be used to indicate Injection, crizanlizumab-tmca, 1 mg for reimbursement purposes.
C9053 belongs to Other Medical Items or Services Type of Service and has been in effect since Jul 01, 2020.
Inj, crizanlizumab-tmca
C9053 code information
| HCPCS code: | C9053 |
| Description: | INJECTION, CRIZANLIZUMAB-TMCA, 1 MG |
| Effective Date: | Jul 01, 2020 |
| Added Date: | Apr 01, 2020 |
| Termination Date: | HCPCS C9053 was terminated on Jun 30, 2020 |
| Pricing indicator: | 53 - STATUTE |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
9 - OTHER MEDICAL ITEMS OR SERVICES
F - AMBULATORY SURGICAL CENTER (FACILITY USAGE FOR SURGICAL SERVICES)
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to C9053